What's Happening?
Gilead Sciences, Inc. has announced the promotion of Keeley Wettan to the position of executive vice president and general counsel, Legal & Compliance. Wettan has been with Gilead for 14 years, previously serving as senior vice president leading the Global Legal Business Partners team. She has played a crucial role in supporting the launch of innovative medicines, including lenacapavir, a twice-yearly HIV prevention drug. Before joining Gilead, Wettan was an attorney at Simpson Thacher & Bartlett in New York City.
Why It's Important?
Keeley Wettan's appointment as general counsel at Gilead Sciences underscores the company's commitment to strong legal leadership as it continues to innovate in the biopharmaceutical sector. Her experience and contributions to the launch
of groundbreaking medicines highlight her capability to navigate complex legal and regulatory landscapes. This leadership change is significant for Gilead as it seeks to maintain its competitive edge in developing and distributing life-saving treatments. Wettan's expertise will be vital in ensuring compliance and supporting the company's strategic goals, potentially impacting the broader pharmaceutical industry.
